TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Fibrocytes density in quadricipital biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of aprocitentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf of aprocitentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Therapy Intensity Level (TIL) Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Kidney Transplant Medication Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of nasal CD8+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Binocular Distance Corrected Near Visual Acuity (DCNVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum tolerated dose (MTD) of IMM2902
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acquisition of frontal and posterior EEG data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Coma recovery scale-revised
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from the p300 in electroencephalogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from resting-state in electroencephalogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from TEP in electroencephalogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from PCI in electroencephalogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of Blinatumomab
Endpoint domain: Adverse events/effects
Primary endpoint: fatigue status
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Clinical findings of patients with Candida osteoarticular infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in low-attenuated plaque volume (LAPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Comparison of elective cervical cerclage methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difficulty of Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difficulty of Laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Observer Scar Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: fMRI assessed neural network connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fMRI-assessed resting connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in venous malformation related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average daily fluid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Lean Soft Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Appendicular Lean Soft Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Fat Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on change management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Jump Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: follistatin levels in metabolic evaluation of obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Plasma nicotine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to Persist in College
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Temperature evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer Therapy Related Cardiac Dysfunction Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of ECG abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of vital sign abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax of BIC and LEN at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCtau of BIC and LEN at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ctrough of BIC and LEN at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Experiencing Treatment-Emergent Adverse Events (TEAEs) Through Week 24
Endpoint domain: Adverse events/effects
Primary endpoint: CNS disease control rate (DCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of teachers engaging with and finishing the program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of patients with ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: R2 value of ablated lesion depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: R2 value of ablated lesion width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: R2 value of ablated lesion area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Anxiety Scale mean score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analog Scale mean score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Scores on User Experience Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety and tolerability of CHK-336
Endpoint domain: Adverse events/effects
Primary endpoint: EEG effective connectivity (dDTF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG connectivity inflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG connectivity outflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG band power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Migraine incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Aura incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Utilization of the Flex Nutrition Program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent Residual Viable Tumor (%RVT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Preferences about dentists' appearance concerning their PPE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: M wave and H reflex recruitment curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: H reflex post-activation depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: F waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: T reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of Personality Functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rapid response team activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients in target range of LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients in target range of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of Infiltration of Gadolinium contrast agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grit
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of pathological interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of intraoperative adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline Barthel Index 100
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline 30 Second Sit to Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at first mental health visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: On-treatment ovulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Post-treatment ovulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Time to hemostasis during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Treatment success at 12 months post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: electromyographic activity of posterior oblique sling muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Early progressive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Long survivors
Endpoint domain: Mortality/survival
Primary endpoint: Number of Patients with Relapse or Recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Glucose iAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Opioid Use in oral morphine equivalents (OME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Pain Inventory - current pain subscale (0-10)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in level of GCF lipoxin A4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Progression free survival (PFS) by biomarker status
Endpoint domain: Mortality/survival
Primary endpoint: Cohen-Mansfield Agitation Inventory (CMAI) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in The Patient Health Questionnaire-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in The Generalized Anxiety Disorder-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area Under the Concentration curve (AUC) of LY3971297
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Drug Concentration (Cmax) of LY3971297
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with a demonstrable molecular response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major pathological remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of high Adverse Childhood Experiences (ACE) score
Endpoint domain: Adverse events/effects
Primary endpoint: Tryptophan requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Extubating time after MSC transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The number of times and total duration of re-intubation after extubating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mortality of BPD
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in endothelial function at 7 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in peak cardiopulmonary parameters at 7 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in aerobic efficiency at 7 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Length of time to administer medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of participants in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability through elevate scores on the Virtual Reality Impression Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants Achieving IGA-TS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to full feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fraction of patients in steroid-free remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of I-124 evuzamitide for diagnosing cardiac amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity of I-124 evuzamitide for diagnosing cardiac amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: depletion of EpCAM-positive tumor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical Functional Status of the Ankle and Foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Index of Functional Disability of the Foot and Ankle in Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Index of Functional Disability of the Foot and Ankle in Sports Activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Myocardial oxygenation reserve (MORE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Selection of appropriate nostril for nasotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of suicide
Endpoint domain: Mortality/survival
Primary endpoint: Suicide tendency
Endpoint domain: Adverse events/effects
Primary endpoint: Pain scores using the visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Screw Placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Active Knee Extension Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sit and toe touch test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Visual Motion Discrimination Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of mesenchymal stromal cell intravenous administration
Endpoint domain: Adverse events/effects
Primary endpoint: efficacy of mesenchymal stromal cells in preventing post-TBI brain axonal injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in transcutaneous carbon dioxide (CO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bony fusion success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Clinical Global Impression score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in NIH Examiner scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Complete response (CR) rate at D30 post CAR-T
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration and severity of cytopenias post CAR-T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of infections D30 post CAR-T
Endpoint domain: Adverse events/effects
Primary endpoint: FLACC Pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ordinal shift of modified Rankin Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PRPP assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COPD diagnosis performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Identification of pre-COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Identification of those at risk of developing COPD within 1-year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from Baseline in Working Memory Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline in Speech Recognition in Noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline in Auditory Attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Retention in treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Retention in study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Treatment adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Load-dependent arterial stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Structural arterial stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: A1c - Marker of overall glucose control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of headache days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self perception of pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MRSA infection rates in children
Endpoint domain: Adverse events/effects
Primary endpoint: First need of opioid analgesia
Endpoint domain: Adverse events/effects
Primary endpoint: World Health Organization Quality of Life Module (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lumbar flexion (Hand-finger ground distance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar lateral flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Quality of Life scoring (OAB)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: drug tolerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment persistence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lymphedema Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lower Extremity Perimeter Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transcranial doppler measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: optic nerve envelope diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: quantitative pupillometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Confirmed objective response (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in expired air carbon monoxide (CO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with volumetric Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total abundance of bifidobacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Autism Mealtime Behavior Inventory (BAMBI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inventory of food preferences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fidelity
Endpoint domain: Delivery of care
Primary endpoint: Endotracheal Intubation Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in range of motion of pelvis, joints of lower limb and foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper body Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CTS symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transplant Allocation Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Hip Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Patient Reported Questionnaire Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinician Reported Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of MTT
Endpoint domain: Adverse events/effects